Core Points - He Eye Hospital (301103.SZ) has disclosed a draft for its 2025 restricted stock incentive plan, proposing to grant a total of 6.37 million shares, with an initial grant of 5.1 million shares [1] - The number of recipients for the initial grant will not exceed 240 individuals [1] - The grant price for the restricted stock is set at 13 yuan per share [1] - The effective period of the incentive plan will last from the date of grant until all shares are vested or become invalid, with a maximum duration of 60 months [1]

Group 1 - The core point of the article is the approval of the 2025 Restricted Stock Incentive Plan by the Board of Directors of Sichuan Jinshi Technology Co., Ltd, aimed at enhancing the company's long-term incentive mechanism and attracting talent [4][6][11] - The Board meeting was held on September 19, 2025, with all directors present, and the meeting's procedures complied with relevant laws and regulations [2][3] - The incentive plan is designed to align the interests of shareholders, the company, and key personnel, ensuring the achievement of strategic goals without adversely affecting operations [4][7][11] Group 2 - The Board approved the management measures for the implementation of the 2025 Restricted Stock Incentive Plan, which aims to maximize shareholder interests [7][10] - The Board proposed to authorize the Board to handle matters related to the 2025 Restricted Stock Incentive Plan, including determining eligibility and adjusting stock quantities as necessary [11][12] - A special resolution will be submitted to the shareholders' meeting for approval, with the first temporary shareholders' meeting scheduled for October 15, 2025 [15][20][21] Group 3 - The meeting will combine on-site and online voting, allowing shareholders to participate remotely [22][34] - The registration date for shareholders to attend the meeting is set for October 9, 2025, and various registration methods are provided [24][30] - The meeting will discuss the proposals related to the incentive plan, which requires a two-thirds majority for approval [27][28]

Core Viewpoint - The company has completed the registration of the first grant of the 2025 restricted stock incentive plan, involving 2,188,000 shares, which accounts for 1.56% of the total share capital prior to the grant [2][4][15]. Group 1: Incentive Plan Details - The first grant of restricted stock involves 2,188,000 shares, allocated to 198 incentive recipients [2][5]. - The grant date for the restricted stock is set for September 8, 2025, with the listing date on September 24, 2025 [5][12]. - The restricted stock is sourced from the company's directed issuance of A-share common stock to the incentive recipients [5][8]. Group 2: Approval Process - The approval process for the incentive plan included multiple meetings of the board and supervisory committee, culminating in a shareholder meeting on September 3, 2025, which approved the plan [3][4][12]. - Adjustments were made to the number of recipients and shares granted, reducing the initial plan from 209 recipients and 2,293,000 shares to 198 recipients and 2,188,000 shares [4][11]. Group 3: Performance Conditions - The release of the restricted stock is contingent upon meeting specific performance targets over the 2025-2027 fiscal years, with annual assessments [7][9]. - The performance metrics include revenue growth rate and net profit growth rate, which will determine the percentage of shares that can be released from restrictions [9][10]. Group 4: Financial Implications - The estimated cost of the incentive plan over four years is projected to be 53.5841 million yuan, impacting the company's net profit during the effective period [16][17]. - The funds raised from the incentive plan will be used to supplement the company's working capital [16]. Group 5: Shareholder Impact - Following the completion of the restricted stock grant, the total share capital will increase from 140,446,000 shares to 142,634,000 shares, slightly reducing the controlling shareholder's ownership percentage from 41.44% to 40.80% [14][15].

Core Points - The company has completed the initial grant registration of the 2025 restricted stock incentive plan, with a total of 1,303,180 shares granted at a price of 14.60 yuan per share to 12 core technical and business personnel [1][4][5] Group 1: Incentive Plan Details - The initial grant date for the restricted stock was September 3, 2025 [3] - The total number of shares granted is 1,303,180 [4] - The grant price is set at 14.60 yuan per share [6] - The shares are sourced from the company's repurchased A-shares [6] - The effective period of the incentive plan lasts up to 48 months from the grant date [7] - The lock-up period for the granted shares is 12 months and 24 months [8] - The unlocking of shares will occur in two phases, contingent on performance assessments [9] Group 2: Performance Assessment - The performance assessment for the initial grant will be conducted over the years 2025 and 2026 [10] - The performance targets are based on the company's audited consolidated financial statements [11] - If the performance assessment results in a "not qualified" rating, the corresponding shares will be canceled [12][13] Group 3: Financial and Structural Impact - The total funds raised from the stock grant amount to 19,026,428 yuan, which will be used to supplement the company's working capital [15] - The total share capital of the company remains unchanged post-grant, thus not affecting earnings per share [15] - The shareholding ratios of the controlling shareholders and actual controllers remain unchanged [15] Group 4: Share Repurchase Background - The company completed a share repurchase plan, acquiring 1,476,155 shares at a total cost of approximately 20 million yuan [16] - The shares granted in the incentive plan are sourced from the repurchased shares [16]

Core Points - Jinshi Technology (002951.SZ) announced a restricted stock incentive plan for 2025, proposing to grant 3.8722 million shares, which accounts for approximately 0.96% of the company's total share capital as of the announcement date [1] - This grant is a one-time allocation with no reserved rights, and the total number of shares involved in all effective stock incentive plans does not exceed 10% of the company's total share capital [1] - No individual incentive recipient will receive more than 1% of the company's total share capital through all effective stock incentive plans [1]

Summary of Key Points Core Viewpoint - Xianheng International (605056) has announced a restricted stock incentive plan for 2025, aiming to enhance employee motivation and align their interests with the company's performance [1] Company Announcement Summary - Xianheng International plans to grant 6 million shares of restricted stock to 174 incentive recipients, representing 1.46% of the company's total share capital [1] - The stock will be sourced from shares repurchased from the secondary market, with a grant price set at 7.29 yuan per share [1] - The incentive recipients include senior management and core personnel, excluding independent directors and supervisors [1] - The plan has a maximum validity period of 48 months, with lock-up periods of 12, 24, and 36 months, and the release of restrictions tied to performance metrics [1] - Performance targets for the release of restrictions are based on revenue and net profit from 2025 to 2027, with individual performance evaluations categorized as excellent, qualified, or unqualified, corresponding to release ratios of 100%, 80%, and 0% respectively [1]

Core Viewpoint - Shanghai Huid Technology Co., Ltd. has completed the registration of the reserved portion of its 2024 restricted stock incentive plan, granting 621,750 shares at a price of 6.90 yuan per share to 30 eligible participants, following an adjustment from the previous price of 7.27 yuan per share [2][22]. Group 1: Restricted Stock Grant Details - The reserved portion of restricted stock was granted on August 29, 2025, with a total of 621,750 shares allocated [3][5]. - The adjustment of the grant price from 7.27 yuan to 6.90 yuan was approved by the board due to the completion of the 2024 annual profit distribution [2][22]. - The total number of shares after the grant increased from 141,132,667 to 141,754,417 [17][22]. Group 2: Performance Conditions and Vesting - The vesting of the restricted stock is contingent upon meeting performance targets for the fiscal years 2024, 2025, and 2026, with annual assessments [9][12]. - If the company fails to meet the performance targets, the corresponding restricted stock will not be released and will be subject to buyback at the grant price plus interest [12][14]. Group 3: Financial Impact and Use of Funds - The funds raised from the restricted stock grant will be used to supplement the company's working capital [18]. - The stock option plan is expected to have a minor impact on the company's net profit due to the amortization of stock payment expenses, but it is anticipated to enhance overall company performance [19][20].

Group 1 - The core point of the article is the announcement of Bluefeng Biochemical's restricted stock incentive plan, which involves granting 20.03 million shares to 72 individuals at a price of 2.64 yuan per share, representing 5.63% of the company's total share capital before the announcement [1] - The effective period of the restricted stock is up to 36 months from the completion of the registration of the stock grant [1] - As of the first half of 2025, Bluefeng Biochemical's revenue composition is 77.39% from photovoltaic products and 22.61% from pesticides [1] Group 2 - The current market capitalization of Bluefeng Biochemical is 1.9 billion yuan [1]

Core Viewpoint - Hairong Cold Chain (603187.SH) has disclosed a draft for its 2025 restricted stock incentive plan, aiming to grant 4.054216 million shares of restricted stock to 149 incentive recipients at a price of 7.37 yuan per share [1] Summary by Sections - **Incentive Plan Details** - The incentive plan is set to be effective from the date of completion of the restricted stock grant registration until all granted restricted stocks are fully released from restrictions or repurchased and canceled, with a maximum duration of 36 months [1]

Core Viewpoint - 博科测试 has announced a draft for its 2025 restricted stock incentive plan, aiming to grant up to 1.075 million shares of the second category of restricted stock to 25 incentive recipients, with an initial grant of up to 875,000 shares at a price of 33.20 yuan per share [1] Group 1 - The total number of incentive recipients for the stock incentive plan is 25 [1] - The effective period for the second category of restricted stock is from the grant date until all shares are vested or become invalid, with a maximum duration of 48 months [1] - The initial grant of restricted stock is capped at 875,000 shares [1]